Cediranib

Biomarkers predict brain tumor's response to therapy

... growth factor therapy, specifically cediranib. cediranib is a highly potent inhibitor of vascular endotheli...tion prior to and one day after patients' received cediranib using an advanced MRI technique. They performed bl...ters and treatment response after a single dose of cediranib in 31 patients with recurrent glioblastoma; all bi...

Drug Improves Survival in Mice With Brain Tumors

... cediranib reduces tissue swelling better than steroids, tea...found that the experimental anti-angiogenesis drug cediranib reduced edema and improved survival in mice with g... patient deaths." Previous research showed that cediranib temporarily normalized abnormal, leaky blood vesse...

Angiogenesis inhibitor improves brain tumor survival by reducing edema

...describes how treatment with the experimental drug cediranib reduced edema and improved survival in three mouse...ny factors combine to cause patient deaths." cediranib inhibits the potent angiogenesis factor VEGF, whic...ssel structure and function. Mice treated with cediranib were found to have significant reductions in the s...

Drugs in the pipeline: new therapies that could change treatment strategies

...ma, researchers observed that daily treatment with cediranib decreased tumor volume by more than half in 56 per...ays and overall survival of 221 days. In addition, cediranib was found to alleviate brain swelling a major cause of morbidity among these patients. cediranib is a selective signaling inhibitor for vascular en...

Cediranib in Medical Technology

Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)

Phase II GBM study presented at ASCO with cediranib - a selective VEGF signaling inhibitor - shows over a quarter of patients alive and progression- free at six months(1) CHICAGO, June 04, 2007 /PRNewswire/ -- Data for the investigational agent cediranib (AZD2171) were presented today at the annua...